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ABSTRACT

Kidney transplant prevalence and costs have been increasing steadily in the past few
decades and this trend is anticipated to continue for years to come. Patient outcomes are
heavily influenced by the amount of time they are waiting for a transplant and by the quality of
care they are receiving up to the transplant. This paper intends to increase positive patient
outcomes and decrease costs by identifying potential kidney transplant patients earlier than
traditional methods. I use medical claims data to determine common risk factors of all patients
who have received a kidney transplant. For the control group I include all patients who have
not received a kidney transplant. I used a binary logistic regression utilizing common risk
factors determined by the claims data to determine what factors are significant and which ones
have a larger impact on predicting kidney transplantation. This approach attempts to predict
patient health outcomes using claims data instead of clinical data which is often used in other
research methods.
The results of my analysis were that the risk factors found in clinical research of kidney
transplantation were the same risk factors found using medical claims data. I determined
diabetes, hypertension and end stage renal disease were strong indicators of potential kidney
transplantation using claims data alone. My conclusion is that medical claims data can be used
in place of clinical data when clinical data is not available or does not exist.
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CHAPTER I
INTRODUCTION
Kidney transplantation is a life changing procedure that is expensive and has the
potential for serious complications. To increase the patient’s survival time after a kidney
transplant it is important to intervene with the patient early on in the diagnosis to ensure
proper treatment is given leading up to the transplant. This intervention will likely lead to the
best outcome for the patient and help reduce any unnecessary procedures. It will also reduce
costs because much of the costs associated with kidney transplant can occur before the
transplant actually takes place. According to (Laupacis, 1996) the expenses associated with pretransplant costs such as dialysis can cost more than the transplant itself and the quality of life of
the patient decreases the longer the patient is on dialysis (Meier-Kriesche, 2002). These
expenses can range from $7,000 for home dialysis to over $24,000 or more for annual dialysis
costs (Hoffstein, 1976). These costs are higher today although the disparity between treatment
options remains. This is why it is important to intervene with the patient early and ensure they
are getting care from quality and cost effective providers.
Not only have costs been increasing but kidney transplant prevalence has also been
increasing. As shown in the chart below (Figure 1) the annual number of kidney transplants has
been increasing steadily since 1988 when there were fewer than 10,000 transplants per year to
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2009 when there were almost 18,000 transplants. This trend will continue as long as long as
kidney transplantation is the only option for those with end stage renal disease.

Figure 1: Annual Number of Kidney Transplants From 1988 to 2009

Even if all the proper steps are taken to ensure the patient is receiving the best care
given by the highest quality clinics there is still a shortage of kidneys available for
transplantation. Because of this, some patients can be on the kidney transplant waiting list for
years waiting for a matching donor kidney. By intervening early in the diagnosis it is possible to
inform the patient of their best and most cost effective treatment options early and get them
on the waiting list at the earliest possible time. Even a simple thing like having the patient on
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home dialysis can save thousands of dollars and possibly lead to better health outcomes for the
patient.
Health care costs have been rising steadily for many years and a part of this increase is
due to inefficient or unnecessary care. By steering patients to high quality and low cost
providers it is possible to increase the likelihood of successful treatments and eliminate
unnecessary expenses for the patient. High quality providers are more likely to reduce overall
costs by eliminating unnecessary procedures and increasing their patient’s health to prevent
more doctor visits in the future. Kidney transplantation is just a small part of total healthcare
costs but this is one area where it is possible to intervene in care and help reduce costs and
increase health outcomes if the potential for kidney transplantation is identified early.
Using claims data in place of clinical data can benefit researches in many ways and has
the potential increase the identification of various diseases. The use of claims data can help
eliminate selection bias that often occurs in research using clinical data. For example, in my
research I am making no decisions on whom to include or exclude from my data set. Any claim
contained in the CMS data set is included and there is no other selection criterion on what data
should be excluded from the data set. This differs from many clinical studies where the
researcher has to choose which members to include and this selection can introduce selection
bias whether it is intentional or not. As stated earlier, the claims data for this analysis is
Medicare claims data obtained from the Center for Medicare & Medicaid Services (CMS). The
claims I used include hospital and physician claims starting at the transplant date and going
backwards to the earliest claims available. For the study group I identified all patients who
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have received a kidney transplant in the past and looked for specific diagnosis codes, procedure
codes, and any other variables that could be important in predicting kidney failure. After
identifying all patients that have received a transplant, I compiled my control group which
consisted of all other patients in the data that did not receive a kidney transplant. For the
group who has not received a transplant I will look at all claims data available regardless of
when the claim occurred. What I attempted to determine are the earliest indicators of
potential kidney failure which in turn lead to kidney transplantation.
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CHAPTER II
LITERATURE REVIEW
There has been a wide range of research done on the topic of what risk factors lead to end
stage renal disease and kidney transplantation. The research varies from topics focused on what
clinical risk factors are associated with kidney failure to what behaviors may contribute or
complicate existing kidney diseases. However, there has not been much research done on
whether claims data alone can be used to predict kidney failure, as I am doing for this analysis.
A study done by Hsu (2009) researched 177,570 individuals in a northern California health
system who agreed to participate in annual checkups for a ten year period. The study started in
1964 and followed these individuals in the US Renal Data System registry through the year 2000.
Hsu found a total of 842 cases of end stage renal disease out of the initial 177,570 participating in
the study; which is .47% of the total population. Of these 842 participants who were identified as
having end stage renal disease, there were many potential risk factors discovered. These risk
factors align with what was found in other studies as well and helps to confirm that these factors
can contribute to decreased kidney function. Hsu also mentions some “novel” risk factors such as
smoking, which was also included in some of the models he analyzed. Hsu used five different
models, each with different risk factors. The final model used in the study was a multivariate
model which includes the established risk factors as well as some the novel risk factors. Significant
risk factors Hsu discovered were sex, old age, proteinuria, diabetes, low educational attainment,
5

race, high blood pressure, body mass index, and serum creatinine level. Hsu found that the two
most important risk factors are proteinuria and excess weight.
Perry (1995) performed a similar study but only included hypertensive veterans as
subjects. The goal of his study was to determine whether or not there is a relationship between
high blood pressure and end stage renal disease. This study included 5730 black and 6182 white
male veterans identified through the Veterans Hypertension Screening and Treatment Program
Clinics. After a 13.9 year follow up, 5337 of the patients died and 245 developed end stage renal
disease. Perry used a proportional hazards modeling to fit multivariate survival models in order to
determine if there is an effect on end stage renal disease with treatment for high blood pressure.
Important risk factors observed in this study were being black or diabetic which could more than
double the odds of the patient developing end stage kidney disease. Having a history of urinary
tract problems or having high pretreatment SBP are also important risk factors of developing end
stage renal disease according to this study.
Diabetes is considered one of the major risk factors associated with end stage renal disease
and there are many studies looking at this relationship. Ritz (1999) found that with the increase in
type II diabetes there has also been an increase in end stage renal disease; particularly in countries
with a western lifestyle. Ritz hypothesized that end stage renal disease was developed due to
subjects with hypertension living longer than they had in the past. With the advances in
treatment for hypertension it’s possible to live longer lives but other complications of
hypertension also have more time to develop.
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Diabetes is one of the most common risk factors in developing end stage renal disease but
it can affect different races in different ways. Cowie (1989) conducted a study looking at the
difference between black and white diabetics and how they differ in developing end stage renal
disease. Cowie concluded black men were 2.6 times more likely to develop end stage renal
disease than their white counterparts. This added variable can further complicate studying the
causes of kidney failure especially when demographic information is not available.
In addition to these cohort studies, clinical and demographic data is often used to study
end stage renal disease risk factors. Most often both types of data are used as in the study done
by Tangri (2011). This study used Cox proportional hazards regression methods to determine
significant risk factors of end stage renal disease. The results of the study determined the most
accurate model included age, sex, estimated GFR, albuminuria, serum calcium, serum phosphate,
serum bicarbonate, and serum ablumium. Tangri concluded that the model created in this study
can be used to successfully predict kidney failure in patients with stage 3 to stage 5 chronic kidney
disease.
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CHAPTER III:
METHODOLOGY
The data I am using comes from the Centers for Medicare & Medicaid Services (CMS).
Specifically, the data is Medicare claims data from 2008-2010 which includes member data,
inpatient claims, outpatient claims, pharmacy claims, and provider claims. In total, there will be
approximately 220 million claims analyzed. I chose to use this data source because it is
provided for public use and has no identifying information on the claim so all the claims data
remains completely confidential. My main analysis will focus on diagnosis codes and other
information provided on a medical claims which makes this data a very reasonable and reliable
source for my analysis. In addition, since this data is Medicare data the claims will be coming
from an older population and these are the people who will normally be receiving kidney
transplants.
The quality of the data is very good; however, there can be some inconsistencies in the
data caused primarily by human error. In some cases claims are coded incorrectly by the
providers and this data is then passed on to the claims adjudication system. When this happens
the member may have incorrect diagnosis or procedure codes listed on their claims which will
affect how the member is flagged for specific disease diagnosis. When a claim is coded
incorrectly, the error is usually caught by either the insurance company processing the claim or
the provider; however, it may take time to reprocess the correct claim so there still may be
8

errors in the data. Another issue with the quality of the data is that patients can move and
switch health plans so the data may not follow the patient to their new health plan. Using CMS
data this issue should not be too much of an issue, but it is something consider when analyzing
claims data.
The first step in my analysis is to identify all the patients who have received a kidney
transplant. To identify those with a kidney transplant I looked for a diagnosis code of V420 and
flagged those members as “received a kidney transplant”. Then, I looked at all of these
member’s claims up to the kidney transplant date. I only wanted to look at claims data before
the transplant date since I am looking for risk factors leading to a kidney transplant, not factors
after a transplant takes place.
I chose to run a binary logistic regression to complete my analysis. I chose this type of
analysis for many different reasons. First of all, there is no linear relationship with my
independent variables and dependent variable so I was unable to perform an OLS regression.
Secondly, my goal in this analysis is to predict the likelihood of a patient in receiving a kidney
transplant. The maximum likelihood estimation associated with the binary logistic regression
makes analyzing each independent variables influence on the dependent variable relatively
easy by looking at each variables corresponding odds ratio. Also, my use of dummy variables
makes a binary logistic regression a very good choice. Because diagnosis codes are not
continuous variables, I converted all of my diagnosis codes into dummy variables for each
specific diagnosis. The initial list of risk variables along with the name of the corresponding
dummy variable is listed in the below table (Table 1). For example, in the case of the end stage
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renal disease diagnosis of 5856 a dummy variable was created called “End Stage Renal Disease”
and the field was marked with a 1 if the patient had this diagnosis and marked with a 0 is there
was no history of this diagnosis. This was done in a similar manner for all other diagnosis codes
as well as with the other risk factors I initially looked at. In the below table the % indicates a
wild card. Some diagnosis codes and prescription drug NDC codes have more than one code
indicating the same drug or diagnosis.
Table 1: Risk Factors and Dummy Variable Names
Risk Factor

PROTEIN URINE TEST PROCEDURE
CODE
Risk Factor

CPT Code

Risk Factor

84155, 82570, 84156
Demographic Variable

NDC

CALCITROL RX

000930657%%

CALCIUM ACETATE RX

000540088%%

AGE 50-59

Age 50-59

FUROSEMIDE RX

0037802%%%%

AGE 40-49

Age 40-49

ALLOPURINOL RX

003780137%%

MALE

Male

INSULIN RX

000882220%%

LIPITOR RX

00071015%%%

Risk Factor

TIN

FAIRVIEW

410991680

NORVASC RX

000691540%%

HENNEPIN

411461900

PHOSLO RX

492300640%%

HEALTHSPAN

363261413

RENAGEL RX

584680021%%

411356741

RENAL CAPS RX

602580162%%

KIDNEY SPECIALISTS
Risk Factor

Therapy Class Code

Risk Factor

ICD Code

DIHYDROPYRIDINES THERAPY CLASS RX

242808

END STAGE RENAL DISEASE
DIAGNOSIS

5856

HMG-COA REDUCTASE INHIBITORS
THERAPY CLASS RX

240608

UNSPECIFIED DISORDER OF
KIDNEY AND URETER
DIAGNOSIS

5939

ADRENALS THERAPY CLASS RX

680400

CHRONIC KIDNEY DISEASE
DIAGNOSIS

585%

BETA-ADRENERGIC BLOCKING AGENTS
THERAPY CLASS RX

242400

DIABETES DIAGNOSIS

250%

INSULINS THERAPY CLASS RX

682008

HYPERTENSION DIAGNOSIS

403%

LOOP DIURETICS THERAPY CLASS RX

402808

DIALYSIS COMPLICATIONS

99673

OPIATE AGONISTS THERAPY CLASS RX

280808

ANGIOTENSIN-CONVERTING ENZYME
INHIBITORS THERAPY CLASS RX

243204
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The initial list of diagnosis and procedure codes is quite extensive and would have been
too lengthy to include in my final model. In order to minimize the risk factors and make the
analysis more feasible, I started by looking at what risk factors were insignificant and could be
safely removed from my analysis. My analysis started with a lengthy list of variables, shown
below (Table 2), along with their corresponding point estimates and significance test scores
derived from my binary logistic regression. There were a variety of variables which I expected
to be significant that were actually shown as being insignificant along with point estimates that
did not seem logical. As you can see from the below list, the vast majority of the variables are
not significant and the ones that I would expect to be significant have a negative point estimate
which goes against all previous research on which variables lead to kidney transplantation.

Table 2. Initial Regression Results

Parameter
END STAGE RENAL DISEASE
UNSPECIFIED DISORDER OF THE
KIDNEY
RELEASE_URETHRAL_STR
CHRONIC KIDNEY DISEASE
CORONARY ATHEROSCLEROSIS
RENAL DIALYSIS COMPLICATIONS
DIABETES

Standard
Error
0.26612 0.15516

DF

Estimate

1

ChiSquare

Pr >
ChiSq

2.9417

0.0863

1

-0.50499

0.1426

12.5405

0.0004

1
1
1
1
1

-0.42647
-0.10038
-0.10426
-0.11067
0.00773

0.20483
0.16433
0.18971
0.16213
0.18071

4.3349
0.3731
0.302
0.466
0.0018

0.0373
0.5413
0.5826
0.4949
0.9659
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Table 2. cont.
HYPERTENSION CHRONIC KIDNEY
DISEASE
PROTEIN URINE TEST
MALE
AGE
TEENS
TWENTIES
THIRTIES
FORTIES
FIFTIES
SIXTIES
SEVENTY PLUS
CALCITRIOL
INSULIN
RENAL_CAP
LIPITOR
CALCIUM_ACETATE
NORVASC
FUROSEMIDE
RENAGAL
ALLOPURINOL
PHOSLO
BETA_ADRENERGIC
OPIATE_AGONISTS
HMG_COA_REDUCTASE
DIHYDROPYRIDINES
ANGIOTENSIN_CONVERTI
INSULIN_THER
LOOP_DIURETICS
ADRENALS

1

-0.01991 0.16342

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

-0.15487
0.19827
0.05588
-0.06272
-0.77517
-0.0465
0.74627
1.12802
1.56352
2.04738
-0.06948
0.31487
-0.15797
-0.35738
-0.12243
-0.31119
0.09149
0.05533
-0.52829
0.16335
-0.12222
-0.57826
-0.14777
-0.20104
-0.15115
0.16651
-0.05367
-0.20834
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0.16018
0.13008
0.0127
0.50865
0.54504
0.58715
0.66193
0.72863
0.83135
0.96325
0.15151
0.23441
0.15339
0.15627
0.14944
0.1976
0.16412
0.16896
0.23121
0.16535
0.1509
0.13781
0.15293
0.13186
0.12974
0.22029
0.14544
0.1244

0.0148

0.9031

0.9347
2.3232
19.3531
0.0152
2.0227
0.0063
1.2711
2.3967
3.537
4.5178
0.2103
1.8043
1.0605
5.2298
0.6712
2.4802
0.3108
0.1072
5.2209
0.9761
0.656
17.6067
0.9337
2.3245
1.3573
0.5714
0.1362
2.8047

0.3336
0.1275
<.0001
0.9019
0.155
0.9369
0.2596
0.1216
0.06
0.0335
0.6465
0.1792
0.3031
0.0222
0.4126
0.1153
0.5772
0.7433
0.0223
0.3232
0.418
<.0001
0.3339
0.1274
0.244
0.4497
0.7121
0.094

Since all of my variables are describing a very specific population and because all of
them are dummy variables there is a very good chance there is multicollinearity in my initial
model. To correct for this I removed many of the variables that were correlated with each
other. For instance, the drug Norvasc is used to treat hypertension so if the patient is
diagnosed with hypertension chances are they are also taking Norvasc. This issue occurred for
all of the prescription drugs I initially included in my model so I decided it would be best to
remove all drugs from my regression and simply focus on the disease diagnosis codes. Because
I am solely focusing on diagnosis code data, I also removed the age variables and procedure
code variables from the model. I did this because I wanted to limit any other variables affecting
the outcome of my disease diagnosis variables. I determined that a person’s age could be
correlated with hypertension and diabetes and I wanted to limit the multicollinearity the best
that I could. The below table (Table 3) shows my final model along with point estimates and
confidence intervals for all of the included variables in the model. These variables included in
the final model were all significant at the 95% level and each appeared to contribute to a
patient potentially needing a kidney transplant.
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Table 3: Final Model/Model Fit Statistics
Odds Ratio Estimates

Effect
END STAGE RENAL DISEASE
UNSPECIFIED DISORDER OF THE KIDNEY
CHRONIC KIDNEY DISEASE
CORONARY ATHEROSCLEROSIS
RENAL DIALYSIS COMPLICATIONS
DIABETES
HYPERTENSION CHRONIC KIDNEY DISEASE
Model Fit Statistics

Criterion
AIC
SC
-2 Log L

Point
Estimate
1.854
1.356
1.642
1.23
1.12
1.29
1.092

95% Wald
Confidence
Limits
1.612
2.133
1.137
1.618
1.438
1.877
1.03
1.43
0.950
1.290
1.05
1.53
0.966
1.235

Intercept
Intercept
and
Only Covariates
2665.691 1488.122
2674.03 1554.835
2663.691 1472.122
Testing Global Null Hypothesis: BETA=0

Test
Likelihood Ratio
Score
Wald

Chi-Square
1191.569
4328.2922
971.1524
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DF
7
7
7

Pr > ChiSq
<.0001
<.0001
<.0001

CHAPTER IV:
RESULTS AND INTERPRETATION
The results of the model shows similar results to what has been found in previous research
of what risk factors can lead to kidney failure. Past research has shown that hypertension,
diabetes, end stage renal disease, and coronary atherosclerosis are all leading indicators of
potential kidney transplantation. Using claims data to analyze these common factors I came to
the same conclusion.
The odds ratio calculation is the main factor I used to quantify how strongly my
independent variables are associated with my dependent variable. The odds ratio is calculated by
dividing the probability of the dependent variable being 1 by 1 minus the probability of the
dependent variable being 1.

In my analysis each odds ratio is calculated by dividing the probably of the patient having a kidney
transplant based on each specific risk factor. By looking at the odds ratio estimates provided with
my final output in Table 3 it shows that a person with end stage renal disease is 1.854 times more
like to receive a kidney transplant than someone without a claims diagnosis of end stage renal
15

disease. Logically, this makes sense and is supported by other research and data. When a patient
develops end stage renal disease a kidney transplant is likely the only option so I would expect the
odds ratio on this estimate to be high. Similarly, diabetes is also a leading cause of kidney
transplantation and an odds ratio of 1.29 indicates the patient is 1.29 times more likely to receive
a kidney transplant than someone without this diagnosis. Interestingly, the diagnosis of
hypertension with chronic kidney disease has a relatively low odds ratio only indicating a patient
with this diagnosis as having an increased likelihood of kidney transplantation of 1.092 times that
of someone without that diagnosis. This low odds ratio could be due to the diagnosis being very
specific and some of the variation could be picked up by the chronic kidney disease diagnosis.
The final model seems to have a very good fit compared to an empty model. As shown by
the Model Fit Statistics computed by my SAS program (Table 3) the three criteria used to
determine overall fit all have very high Chi-Square estimates and low P values. This would seem to
indicate the variables I chose to include in my final model are reasonable and I should not reject
my model.
Even though my final model has a limited number of independent variables, it does a
relatively good job of predicting kidney transplantation based on the seven risk factors included.
Of these seven risk factors, the diagnosis of end stage renal disease has the most impact on
predicting if a patient will need a kidney transplant in the future. By looking at all the variables as
a whole, a researcher could use the corresponding odds ratios of all of these variables and predict
which patients will eventually need a kidney transplant with relative confidence. As stated earlier,
using claims data alone could lead to some false positives based on errors in claims data and the
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fact that claims data may not tell the whole story. Even with these limitations, my analysis could
prove to be very useful for someone interested in factors leading to kidney transplantation.
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CHAPTER V:
FUTURE RESEARCH
Overall, claims data paints a good picture of each patient’s overall health and has proven
to be very useful when looking for risk factors leading to kidney transplant. In terms of data to
include in a model I think the data I am lacking most is clinical data. Data such as test results from
blood or urine samples, blood pressure, and heart rate would provide even more insight into the
patient’s health. Although this information would be nice to have, a lot of what is in the claims
data can help explain the outcome of some test results. For example, the results of a GFR test
would indicate what stage of renal failure a patient is in. In this case using the diagnosis code to
show what stage of renal failure a patient is in can be just as useful as the clinical data.
In this analysis I am only looking at the Medicare population for a limited time period of
four years. This population only includes older patients so I’m not looking at the entire
population as a whole. Most people needing kidney transplants are older so this shouldn’t’ have a
large impact on the results, but it should be noted that I’m not looking at all ages and groups of
people. Using claims data older than four years old would also be useful in this analysis to
potentially identify kidney transplant recipients earlier. Chronic kidney disease can develop over a
long period of time and there could be some diagnoses very early in the patient’s care that may be
useful in predicting future kidney transplant recipients.

18

Based on the results of this model it would be interesting to put this method into practice
and attempt to predict future kidney transplant recipients in a health plan. The health plan
researcher could then follow the patients who were flagged as potentially needing a kidney
transplant and see which ones did in fact require a kidney transplant in the future. This could be a
very long process since developing end stage renal disease can take many years but it would be a
good way to validate the model.
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CHAPTER VI:
SUMMARY
Kidney transplantation is a costly and life altering procedure that can potential decrease a
patient’s quality of life. It is important to identify potential kidney failure as early as possible to
help increase positive outcomes for the patient and to help reduce costs associated with end stage
renal disease. By identifying a patient early it is possible to be put on a kidney donor waiting list
earlier to potentially decrease the time waiting for a kidney while the person is on dialysis. The
longer a patient is on dialysis the higher risk they will have of developing complications related to
kidney failure. They can also expect a decreased life expectancy after the transplant.
My analysis confirms what prior clinical research has shown except I am using claims data
in place of clinical data. Major risk factors cited in prior research include diabetes, hypertension,
and end stage renal disease and I also show similar results. Based on these results it may be
possible to predict other potential health outcomes using claims data in place of other research
methods. This may provide useful information to health insurance companies and others who do
not have direct access to clinical data.
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